CoChat

Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis

Takaesu, Yotaro, Nishi, Hirotaka, Kojima, Junya, Sasaki, Toru, Nagamitsu, Yuzo, Kato, Rina, Isaka, Keiichi · 2016 · Journal of Obstetrics and Gynaecology Research
Cited by 79

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Aim: Although there are various hormone therapies, including gonadotropin‐releasing hormone agonist, danazol, levonorgestrel‐releasing intrauterine system, dienogest, and low‐dose estrogen progestin, no consensus opinion has been reached in terms of which medication should be used and for how long it should be administered. We aimed to determine whether dienogest or goserelin is the better postoperative therapy to prevent recurrence of endometriosis. Methods: A prospective cohort randomized study were conducted, including 198 patients diagnosed as having endometriosis. A total of 111 patients were randomly assigned into two groups: the dienogest‐administered group (n = 56) and the goserelin‐administered group (n = 55). Patients were followed for 24 months after laparoscopic surgery. Those who gave consent but desired no postoperative therapy were assigned to the non‐treatment group (n = 79). Recurrence, side‐effects, degrees of menstrual pain and chronic pelvic pain measured by the Visual Analogue Scale were compared among the three groups: the dienogest, goserelin, and non‐treatment groups. Results: No significant difference was observed in the postoperative recurrence rate between the dienogest and goserelin groups. No significant difference was found in the recurrence rate between the goserelin group and non‐treatment group; however, a significant difference was found in the recurrence rate between the dienogest group and the non‐treatment group (P = 0.027). Menstrual pain and chronic pelvic pain were significantly improved in both treatment groups. Side‐effects were markedly observed in the goserelin group as compared with the dienogest group. Conclusion: Dienogest is available for prolonged administration of more than 6 months, so it is more useful than goserelin, which is available only for short‐term administration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jog.13023

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 79

Metadata

Authors
Takaesu, Y., Nishi, H., Kojima, J., Sasaki, T., Nagamitsu, Y., Kato, R., & Isaka, K.
Venue
Journal of Obstetrics and Gynaecology Research
Publisher
Wiley
Published
2016-05-26
Volume
42
Issue
9
Pages
1152-1158
ISSN
  • 1341-8076 (ISSN-L)
  • 1447-0756
OpenAlex
W2398997144
Cited by
79
References
12
FWCI
7.49
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis. https://app.cochat.ai/papers/10.1111/jog.13023
The paper
Takaesu, Y., Nishi, H., Kojima, J., Sasaki, T., Nagamitsu, Y., Kato, R., & Isaka, K. (2016). Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.13023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.